371 related articles for article (PubMed ID: 28273717)
1. ALCAM (CD166) is involved in extravasation of monocytes rather than T cells across the blood-brain barrier.
Lyck R; Lécuyer MA; Abadier M; Wyss CB; Matti C; Rosito M; Enzmann G; Zeis T; Michel L; García Martín AB; Sallusto F; Gosselet F; Deutsch U; Weiner JA; Schaeren-Wiemers N; Prat A; Engelhardt B
J Cereb Blood Flow Metab; 2017 Aug; 37(8):2894-2909. PubMed ID: 28273717
[TBL] [Abstract][Full Text] [Related]
2. Cell surface levels of endothelial ICAM-1 influence the transcellular or paracellular T-cell diapedesis across the blood-brain barrier.
Abadier M; Haghayegh Jahromi N; Cardoso Alves L; Boscacci R; Vestweber D; Barnum S; Deutsch U; Engelhardt B; Lyck R
Eur J Immunol; 2015 Apr; 45(4):1043-58. PubMed ID: 25545837
[TBL] [Abstract][Full Text] [Related]
3. Human T-Lymphotropic Virus Type 1-Induced Overexpression of Activated Leukocyte Cell Adhesion Molecule (ALCAM) Facilitates Trafficking of Infected Lymphocytes through the Blood-Brain Barrier.
Curis C; Percher F; Jeannin P; Montange T; Chevalier SA; Seilhean D; Cartier L; Couraud PO; Gout O; Gessain A; Ceccaldi PE; Afonso PV
J Virol; 2016 Aug; 90(16):7303-7312. PubMed ID: 27252538
[TBL] [Abstract][Full Text] [Related]
4. JAM-A and ALCAM are therapeutic targets to inhibit diapedesis across the BBB of CD14+CD16+ monocytes in HIV-infected individuals.
Williams DW; Anastos K; Morgello S; Berman JW
J Leukoc Biol; 2015 Feb; 97(2):401-12. PubMed ID: 25420915
[TBL] [Abstract][Full Text] [Related]
5. PECAM-1 Stabilizes Blood-Brain Barrier Integrity and Favors Paracellular T-Cell Diapedesis Across the Blood-Brain Barrier During Neuroinflammation.
Wimmer I; Tietz S; Nishihara H; Deutsch U; Sallusto F; Gosselet F; Lyck R; Muller WA; Lassmann H; Engelhardt B
Front Immunol; 2019; 10():711. PubMed ID: 31024547
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of HIV entry into the CNS: increased sensitivity of HIV infected CD14+CD16+ monocytes to CCL2 and key roles of CCR2, JAM-A, and ALCAM in diapedesis.
Williams DW; Calderon TM; Lopez L; Carvallo-Torres L; Gaskill PJ; Eugenin EA; Morgello S; Berman JW
PLoS One; 2013; 8(7):e69270. PubMed ID: 23922698
[TBL] [Abstract][Full Text] [Related]
7. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
[TBL] [Abstract][Full Text] [Related]
8. Dual role of ALCAM in neuroinflammation and blood-brain barrier homeostasis.
Lécuyer MA; Saint-Laurent O; Bourbonnière L; Larouche S; Larochelle C; Michel L; Charabati M; Abadier M; Zandee S; Haghayegh Jahromi N; Gowing E; Pittet C; Lyck R; Engelhardt B; Prat A
Proc Natl Acad Sci U S A; 2017 Jan; 114(4):E524-E533. PubMed ID: 28069965
[TBL] [Abstract][Full Text] [Related]
9. Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system.
Cayrol R; Wosik K; Berard JL; Dodelet-Devillers A; Ifergan I; Kebir H; Haqqani AS; Kreymborg K; Krug S; Moumdjian R; Bouthillier A; Becher B; Arbour N; David S; Stanimirovic D; Prat A
Nat Immunol; 2008 Feb; 9(2):137-45. PubMed ID: 18157132
[TBL] [Abstract][Full Text] [Related]
10. Differential roles for endothelial ICAM-1, ICAM-2, and VCAM-1 in shear-resistant T cell arrest, polarization, and directed crawling on blood-brain barrier endothelium.
Steiner O; Coisne C; Cecchelli R; Boscacci R; Deutsch U; Engelhardt B; Lyck R
J Immunol; 2010 Oct; 185(8):4846-55. PubMed ID: 20861356
[TBL] [Abstract][Full Text] [Related]
11. Intercellular Adhesion Molecule-1 (ICAM-1) and ICAM-2 Differentially Contribute to Peripheral Activation and CNS Entry of Autoaggressive Th1 and Th17 Cells in Experimental Autoimmune Encephalomyelitis.
Haghayegh Jahromi N; Marchetti L; Moalli F; Duc D; Basso C; Tardent H; Kaba E; Deutsch U; Pot C; Sallusto F; Stein JV; Engelhardt B
Front Immunol; 2019; 10():3056. PubMed ID: 31993059
[TBL] [Abstract][Full Text] [Related]
12. ALCAM Mediates DC Migration Through Afferent Lymphatics and Promotes Allospecific Immune Reactions.
Willrodt AH; Salabarria AC; Schineis P; Ignatova D; Hunter MC; Vranova M; Golding-Ochsenbein AM; Sigmund E; Romagna A; Strassberger V; Fabbi M; Ferrini S; Cursiefen C; Neri D; Guenova E; Bock F; Halin C
Front Immunol; 2019; 10():759. PubMed ID: 31031759
[TBL] [Abstract][Full Text] [Related]
13. ACKR1 favors transcellular over paracellular T-cell diapedesis across the blood-brain barrier in neuroinflammation in vitro.
Marchetti L; Francisco D; Soldati S; Haghayegh Jahromi N; Barcos S; Gruber I; Pareja JR; Thiriot A; von Andrian U; Deutsch U; Lyck R; Bruggmann R; Engelhardt B
Eur J Immunol; 2022 Jan; 52(1):161-177. PubMed ID: 34524684
[TBL] [Abstract][Full Text] [Related]
14. Going against the tide--how encephalitogenic T cells breach the blood-brain barrier.
Lyck R; Engelhardt B
J Vasc Res; 2012; 49(6):497-509. PubMed ID: 22948545
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of CNS Viral Seeding by HIV
Veenstra M; León-Rivera R; Li M; Gama L; Clements JE; Berman JW
mBio; 2017 Oct; 8(5):. PubMed ID: 29066542
[TBL] [Abstract][Full Text] [Related]
16. Novel role for ALCAM in lymphatic network formation and function.
Iolyeva M; Karaman S; Willrodt AH; Weingartner S; Vigl B; Halin C
FASEB J; 2013 Mar; 27(3):978-90. PubMed ID: 23169771
[TBL] [Abstract][Full Text] [Related]
17. T-cell trafficking competence is required for CNS invasion.
Lees JR; Archambault AS; Russell JH
J Neuroimmunol; 2006 Aug; 177(1-2):1-10. PubMed ID: 16822552
[TBL] [Abstract][Full Text] [Related]
18. Laquinimod enhances central nervous system barrier functions.
Lühder F; Kebir H; Odoardi F; Litke T; Sonneck M; Alvarez JI; Winchenbach J; Eckert N; Hayardeny L; Sorani E; Lodygin D; Flügel A; Prat A
Neurobiol Dis; 2017 Jun; 102():60-69. PubMed ID: 28235673
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase Cβ as a therapeutic target stabilizing blood-brain barrier disruption in experimental autoimmune encephalomyelitis.
Lanz TV; Becker S; Osswald M; Bittner S; Schuhmann MK; Opitz CA; Gaikwad S; Wiestler B; Litzenburger UM; Sahm F; Ott M; Iwantscheff S; Grabitz C; Mittelbronn M; von Deimling A; Winkler F; Meuth SG; Wick W; Platten M
Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14735-40. PubMed ID: 23959874
[TBL] [Abstract][Full Text] [Related]
20. Postarrest stalling rather than crawling favors CD8(+) over CD4(+) T-cell migration across the blood-brain barrier under flow in vitro.
Rudolph H; Klopstein A; Gruber I; Blatti C; Lyck R; Engelhardt B
Eur J Immunol; 2016 Sep; 46(9):2187-203. PubMed ID: 27338806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
